Randox Shocking Truth

Randox is a multinational corporation that provides diagnostic solutions for healthcare. It has been in the news a lot recently, but not for good reasons. The company has been accused of fraud, corruption, and failing to meet safety standards.
What is Randox?
Randox was founded in 1982 by Peter Fitzgerald. The company is headquartered in Crumlin, County Antrim, Northern Ireland. Randox manufactures and sells a wide range of diagnostic products, including blood tests, urine tests, and genetic tests. It also provides laboratory services to healthcare providers.
Controversies
In recent years, Randox has been involved in a number of controversies. In 2013, the company was accused of bribing officials in Romania to secure a contract. In 2017, it was accused of failing to meet safety standards at its manufacturing plant in Northern Ireland. And in 2019, it was accused of overcharging the NHS for its products.
Fraud and Corruption
Randox has been accused of engaging in fraud and corruption on multiple occasions. In 2013, the company was accused of bribing officials in Romania to secure a contract. The company allegedly paid bribes to Romanian officials in order to win a contract to provide laboratory services to the Romanian government. In 2017, Randox was accused of bribing officials in South Korea to secure a contract. The company allegedly paid bribes to South Korean officials in order to win a contract to provide laboratory services to the South Korean government.
Safety Standards
Randox has also been accused of failing to meet safety standards at its manufacturing plant in Northern Ireland. In 2017, the UK Medicines and Healthcare products Regulatory Agency (MHRA) inspected the plant and found a number of serious safety violations. The MHRA found that the plant was not clean enough and that the company was not following proper manufacturing procedures.
Overcharging the NHS
Randox has also been accused of overcharging the NHS for its products. In 2019, the Public Accounts Committee (PAC) accused Randox of overcharging the NHS by £300 million. The PAC found that Randox had been overcharging the NHS for its blood tests for a number of years.
Calls for an Investigation
There have been calls for an investigation into Randox's practices. In 2019, the PAC called for a Serious Fraud Office (SFO) investigation into Randox. The SFO is currently investigating Randox, but no charges have been filed yet.
The Future of Randox
Randox is facing an uncertain future. The company is facing multiple investigations, and it is unclear whether it will be able to survive. The company has lost a number of contracts in recent years, and its reputation has been damaged. It is possible that Randox will be forced to close down, or that it will be sold to another company.

Randox is a company in crisis. The company has been accused of fraud, corruption, and failing to meet safety standards. It is facing multiple investigations, and its future is uncertain. It is unclear whether Randox will be able to survive, or whether it will be forced to close down.